From lab to clinic: Large-scale recombinant protein production explained
Recombinant protein manufacturing has transformed biotechnology, enabling the production of therapeutic proteins, industrial enzymes, and bioengineered materials. The growing demand for recombinant proteins across regenerative medicine, disease diagnostics, and biopharmaceuticals ...
Robotic gloveless isolator technology enhances regional production of advanced therapeutics
To meet growing demands of advanced therapy manufacturing, production architectures must shift towards agile, efficient manufacturing systems. By integrating robotic gloveless isolator (RGI) technology into bioproduction, manufacturers can meet the ...
Beyond tomorrow with Janet Hoogstraate
Janet Hoogstraate, CEO of NorthX Biologics, recently appeared in an episode of BEYOND TOMORROW, a podcast by Plantvision. Janet discusses challenges and opportunities within Swedish pharmaceutical manufacturing, with a special focus on ...
Driving therapeutic innovation with OMVs and EVs
Outer membrane vesicles (OMVs) and extracellular vesicles (EVs) are revolutionizing biopharmaceuticals, offering cutting-edge vaccines and therapeutic delivery solutions. These nanoscale vesicles hold immense potential to enhance immune responses and serve ...
Personalized medicine and the CDMO: Adapting to a new era of healthcare
Neoantigen cancer vaccines represent a groundbreaking advancement in personalized medicine, offering tailored cancer treatments designed for each patient’s unique tumor profile. These therapies require rapid turnaround from tumor identification to ...
The Nordics are dancing on
What’s hot and what’s not in ATMP? Insights from service providers, investors, and academics at the 2024 BIO-Europe conference in Stockholm. BIO-Europe celebrated its 30th anniversary in Stockholm, Sweden, on ...
Sweden as a pharmaceutical manufacturing country
Based on a blog post by NorthX Biologics’ CEO Janet Hoogstraate at Stockholm Science City Foundation Sweden holds a unique position in life sciences and has, for decades, been a leading ...
The expanding biologics CDMO market: Innovative modalities and the role of NorthX Biologics
The pharmaceutical industry is experiencing a rapid transformation as advanced biologics – viral vectors, recombinant proteins, plasmid DNA, and cell and gene therapies – take center stage. With over 14,800 ...
Protein science and the future of biotherapeutics
The study of proteins is transforming our understanding of human biology and disease, enabling breakthroughs in diagnostics, drug development, and advanced therapies. In this article, Mathias Uhlén, Professor of Microbiology ...